Pascut D - Search Results

1

Antiphospholipid antibodies and lipoprotein(a) in obese children.

Pascut D, Princi T, Donato M, Tamaro G, Parco S. Pascut D, et al. Acta Paediatr. 2009 Apr;98(4):703-7. doi: 10.1111/j.1651-2227.2008.01182.x. Epub 2009 Jan 12. Acta Paediatr. 2009. PMID: 19183123

2

Differences in circulating microRNA signature in Prader-Willi syndrome and non-syndromic obesity.

Pascut D, Tamini S, Bresolin S, Giraudi P, Basso G, Minocci A, Tiribelli C, Grugni G, Sartorio A. Pascut D, et al. Endocr Connect. 2018 Dec 1;7(12):1262-1274. doi: 10.1530/EC-18-0329. Endocr Connect. 2018. PMID: 30352401 Free PMC article.

3

Serum Stem Cell Growth Factor Beta for the Prediction of Therapy Response in Hepatocellular Carcinoma.

Sukowati CHC, Patti R, Pascut D, Ladju RB, Tarchi P, Zanotta N, Comar M, Tiribelli C, Crocè LS. Sukowati CHC, et al. Among authors: pascut d. Biomed Res Int. 2018 Aug 30;2018:6435482. doi: 10.1155/2018/6435482. eCollection 2018. Biomed Res Int. 2018. PMID: 30246025 Free PMC article.

4

Multidrug resistance in hepatic cancer stem cells: the emerging role of miRNAs.

Sukowati CH, Anfuso B, Pascut D, Tiribelli C. Sukowati CH, et al. Among authors: pascut d. Expert Rev Gastroenterol Hepatol. 2015 Jun;9(6):723-5. doi: 10.1586/17474124.2015.1041509. Epub 2015 Apr 28. Expert Rev Gastroenterol Hepatol. 2015. PMID: 25920931

5

Aptamer: A potential oligonucleotide nanomedicine in the diagnosis and treatment of hepatocellular carcinoma.

Ladju RB, Pascut D, Massi MN, Tiribelli C, Sukowati CHC. Ladju RB, et al. Among authors: pascut d. Oncotarget. 2017 Dec 16;9(2):2951-2961. doi: 10.18632/oncotarget.23359. eCollection 2018 Jan 5. Oncotarget. 2017. PMID: 29416827 Free PMC article. Review.

6

Gene and functional up-regulation of the BCRP/ABCG2 transporter in hepatocellular carcinoma.

Sukowati CH, Rosso N, Pascut D, Anfuso B, Torre G, Francalanci P, Crocè LS, Tiribelli C. Sukowati CH, et al. Among authors: pascut d. BMC Gastroenterol. 2012 Nov 15;12:160. doi: 10.1186/1471-230X-12-160. BMC Gastroenterol. 2012. PMID: 23153066 Free PMC article.

7

Correction: Aptamer: A potential oligonucleotide nanomedicine in the diagnosis and treatment of hepatocellular carcinoma.

Ladju RB, Pascut D, Massi MN, Tiribelli C, Sukowati CHC. Ladju RB, et al. Among authors: pascut d. Oncotarget. 2018 Feb 26;9(16):13101. doi: 10.18632/oncotarget.24572. eCollection 2018 Feb 27. Oncotarget. 2018. PMID: 29569656 Free PMC article.

8

Serum AP-endonuclease 1 (sAPE1) as novel biomarker for hepatocellular carcinoma.

Pascut D, Sukowati CHC, Antoniali G, Mangiapane G, Burra S, Mascaretti LG, Buonocore MR, Crocè LS, Tiribelli C, Tell G. Pascut D, et al. Oncotarget. 2019 Jan 8;10(3):383-394. doi: 10.18632/oncotarget.26555. eCollection 2019 Jan 8. Oncotarget. 2019. PMID: 30719231 Free PMC article.

9

A comparative characterization of the circulating miRNome in whole blood and serum of HCC patients.

Pascut D, Krmac H, Gilardi F, Patti R, Calligaris R, Crocè LS, Tiribelli C. Pascut D, et al. Sci Rep. 2019 Jun 4;9(1):8265. doi: 10.1038/s41598-019-44580-x. Sci Rep. 2019. PMID: 31164669 Free PMC article.

10

Circulatory miRNA as a Biomarker for Therapy Response and Disease-Free Survival in Hepatocellular Carcinoma.

Pratama MY, Visintin A, Crocè LS, Tiribelli C, Pascut D. Pratama MY, et al. Among authors: pascut d. Cancers (Basel). 2020 Sep 29;12(10):2810. doi: 10.3390/cancers12102810. Cancers (Basel). 2020. PMID: 33003646 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

43 results

Search Page

Filters